Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer

Author's Avatar
Jan 04, 2021
Article's Main Image

Dr. Kupiec will leverage three decades of drug development experience at Pfizer, Sanofi and Ciba-Geigy to lead the Company’s Phase 3 development of simufilam for Alzheimer’s disease.